Back to Search Start Over

Revascularization of Left Anterior Descending Coronary Artery in Patients With Single and Multivessel Disease

Authors :
Itzhak Herz
Roni Braunstein
Yaron Moshkovitz
Gideon Uretzky
Einat Zivi
Yanai Ben-Gal
Rephael Mohr
Source :
Chest. 128:804-809
Publication Year :
2005
Publisher :
Elsevier BV, 2005.

Abstract

Study objectives The left anterior descending artery (LADA), particularly when the proximal segment of the vessel is involved, is a challenging area for percutaneous coronary interventions (PCIs); therefore, coronary artery bypass grafting is often considered and sometimes performed even in patients with single-vessel disease involving the LADA. This study compares mid-term results of LADA revascularization with a drug-eluting stent (DES), with off-pump coronary artery bypass grafting (OPCAB) in patients with single-vessel or multivessel coronary artery disease (CAD) Design Matched-groups, retrospective cohort comparison between the DES and OPCAB Patients From June 2002 to December 2003, 354 patients underwent myocardial revascularization of the LADA by OPCAB, and 168 by DES. After matching for age, sex, and extent of CAD, two groups (116 patients each) were used to compare the two revascularization modalities. The groups were similar; however, an ejection fraction of Results The average number of coronary vessels treated per patient in the two groups was similar (OPCAB, 1.97; DES, 1.6; p = 0.581). The 30-day mortality rate was 0.9% in the OPCAB group and 0% in the DES group (p = 0.329). The mean duration of follow-up was 12 months. There was one late death in each group. Angina returned in 31% of patients in the DES group and in 11.2% of the patients in the OPCAB group (p = 0.001). There were 12 reinterventions in the DES group compared to three reinterventions in the surgical group (p = 0.020). The only independent predictor (Cox proportional hazards regression model) of the return of angina (risk ratio [RR], 3.36; 95% confidence interval [CI], 1.57 to 7.14) and reintervention (RR, 3.9; 95% CI, 1.34 to 11.24) was assignment to the DES group Conclusions The mid-term clinical outcome of OPCAB in patients with CAD, including multivessel disease, was better than that for PCIs with only one DES used in patients with similar extents of CAD

Details

ISSN :
00123692
Volume :
128
Database :
OpenAIRE
Journal :
Chest
Accession number :
edsair.doi...........9bd1ffc35f697399932d43f71f1e6b50
Full Text :
https://doi.org/10.1378/chest.128.2.804